4//SEC Filing
POZEN INC /NC 4
Accession 0000899243-16-012923
CIK 0001059790operating
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 5:32 PM ET
Size
9.3 KB
Accession
0000899243-16-012923
Insider Transaction Report
Form 4
POZEN INC /NCPOZN
PAR INVESTMENT PARTNERS LP
10% Owner
Transactions
- Other
Common Stock
2016-02-05−3,863,699→ 0 total
PAR Group, L.P.
10% Owner
Transactions
- Other
Common Stock
2016-02-05−3,863,699→ 0 total
PAR CAPITAL MANAGEMENT INC
10% Owner
Transactions
- Other
Common Stock
2016-02-05−3,863,699→ 0 total
Footnotes (2)
- [F1]These securities are held directly by PAR Investment Partners, L.P. ("PIP"). PAR Group, L.P. ("PAR Group") is the general partner of PIP. PAR Group disclaims beneficial ownership of the securities except to the extent of the pecuniary interest, if any, in such securities as a result of PAR Group's general partner interest in PIP and contingent right to a performance-based advisory fee. PAR Capital Management, Inc. ("PCM") is the general partner of PAR Group which is the general partner of PIP. PCM disclaims beneficial ownership of the securities except to the extent of the pecuniary interest, if any, in such securities as a result of PCM's general partner interest in PAR Group.
- [F2]On February 5, 2016, POZEN, Inc. (the "Issuer") completed a business combination with Tribute Pharmaceuticals Canada Inc. As a result of the business combination, each share of common stock of the Issuer that was owned by PIP was converted into one common share of Aralez Pharmaceuticals Inc.
Documents
Issuer
POZEN INC /NC
CIK 0001059790
Entity typeoperating
Related Parties
1- filerCIK 0001059790
Filing Metadata
- Form type
- 4
- Filed
- Feb 8, 7:00 PM ET
- Accepted
- Feb 9, 5:32 PM ET
- Size
- 9.3 KB